Working closely with you, our Director of Material Sciences, Dr Robert Dennehy will assess the risks of your API process and develop a tailored process development roadmap.
When you submit the form above, we will contact you to arrange a meeting with our team to explore the next steps.
Our Director of Material Sciences, Dr Robert Dennehy will work with you to identify and mitigate the risks in your API process. Together, you and Robert will devise a perfect-for-purpose process development roadmap, allowing you to rapidly take the right steps to accomplish your project objectives. First Time, Every Time.
Expert one-to-one consultancy
De-risk your pharmaceutical pipeline by working alongside our Director of Material Sciences, Dr Robert Dennehy. Dr Dennehy will leverage your already available API, project and formulation data sets to assess the risks of your API process and offer smart mitigation strategies.
Faster and smarter decisions
Better understand your project risks and set the right priorities based on your portfolio needs. Rapidly reach the best decision for your process – First Time, Every Time.
Perfect-for-purpose Process Development Roadmap
Advance your asset to the next step, without surprises or delays. Receive a tailored life-cycle plan of your API to meet your budget, timelines and study needs.
Robert obtained a BSc Hons in Chemistry from Queen Mary College, University of London, in 1988. He was then awarded a PhD from Southampton University in 1992. After his PhD, Robert became a Process and Synthetic Chemist at SmithKline Beecham.